GLP-1 Receptor Agonists in the Surgical Patient: Prevalence, Epidemiology, and Pulmonary Complications
Key facts
- Who runs it
- University of Virginia
- Where
- Charlottesville, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 25,505 people enrolled
- Started
- 1 Jan 2025
- Ended
- 28 Feb 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- GLP-1 Receptor Agonists
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Elective surgery
- Adult patients (≥ 18 years of age)
- Operative sites: main operating room and three outpatient centers
- Anesthesia services
Who cannot take part
- Case sites: labor \& delivery, cardiac catheterization, electrophysiology, endoscopy, and radiology (both medical imaging and interventional)
- Monitored anesthesia care for < 15 minutes
- American Society of Anesthesiologists physical status classification 5
Where in United States
- University of VirginiaCharlottesville, United States
About the trial
What the trial wants to find out
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among adult elective surgical patients is increasing. The exact prevalence is unclear, and the possible association with pulmonary aspiration is a major concern. This study was designed to quantify the prevalence of GLP-1 RA use and the incidence of perioperative aspiration among other 30-day pulmonary complications in adult elective surgical patients at a single institution in 2025.
The 2 groups in the trial
- Elective surgery
Adult elective surgical patients
Treatment: GLP-1 Receptor Agonists
- Subgroup of interest
Adult elective surgical patients with body mass index ≥ 25 kg/m2 who underwent non-brain, non-cardiac surgery with overnight stay after general anesthesia with orotracheal intubation and a surgical duration of at least two hours
Treatment: GLP-1 Receptor Agonists
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 12 November 2026